Delivery Order SPE2DB22D3016-SPE2DB24FAUV1
- Not listed
- This federal contract award is for the delivery of 0.4% RECTIV ointment, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $2,525.37, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp for the supply of a pharmaceutical product, RECTIV 0.4% Ointment 30GM. The $3,705.96 contract has an ultimate completion date of August 1, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive range of medical commodities to support...
- This federal contract award is for the delivery of RECTIV 0.4% OINTMENT 30GM medical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $1,387.96 and a completion date of April 26, 2024. It is a firm-fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award is for the delivery of RECTIV 0.4% ointment in 30 gram units to the Defense Logistics Agency (DLA). The $1,125.26 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. No set-aside designation was used. Amerisourcebergen Drug Corp has an established history of providing pharmaceuticals, medical supplies, and distribution services to support DLA Troop Support...
- This federal contract award is for the delivery of Rectiv 0.4% ointment, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, as a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00. The contract has a ceiling value of $6,011.76 and a completion date of July 7, 2023. This contract does not have a set-aside designation,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,776.34 firm fixed-price delivery order is for the supply of "RECTIV 0.4% OINTMENT 30GM" medical products. The contract has an ultimate completion date of March 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award, valued at $2,173.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567569660 ! RECTIV 0.4% OINTMENT 30GM, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 14, 2025. This award is not designated as a set-aside contract. Amerisourcebergen Drug...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,141.78, is for the delivery of "RECTIV 0.4% OINTMENT 30GM" and has an ultimate completion date of April 9, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The award, valued at $2,904.43, is for the delivery of RECTIV 0.4% ointment 30GM to support federal healthcare programs. The contract has an ultimate completion date of December 10, 2024 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,137.00, is a Delivery Order with a Firm Fixed Price pricing type. It covers the procurement of a pharmaceutical product, "RECTIV 0.4% OINTMENT 30GM," with a completion date of December 9, 2024. The contract does not have a set-aside designation, indicating open competition....
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FAUV1Delivery Order
This federal contract award is for the delivery of RECTIV 0.4% OINTMENT 30GM to the Defense Logistics Agency (DLA). The contract, valued at $4,692.01, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and the contract is for the delivery of the specified pharmaceutical product to a location in Conshohocken, Pennsylvania, with a performance period through May 8, 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 5/7/24 |